Sectors
INM
InMed Pharmaceuticals Inc.
1.33
2 x 0.94
2 x 1.71
bid
ask
+
0.02
1.53%
2 @ 04:00 PM
1.33 +0.00 (0.00%)
| Ytd | 25.47% | |
| 1y | -39.55% |
1.31
day range
1.34
0.57
52 week range
2.33
| Open | 1.32 | Prev Close | 1.31 | Low | 1.31 | High | 1.34 | Mkt Cap | 7.31M |
| Vol | 17.59K | Avg Vol | 914.18K | EPS | -2.82 | P/E | N/A | Forward P/E | -0.75 |
| Beta | 0.71 | Short Ratio | 0.12 | Inst. Own | 8.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 1.38 | 200-d Avg | 1.18 | 1yr Est | 20.00 |
| Income Statement | |||
| Operating Expenses | 4.87M | ||
| Research and Development Expense | 805.74K | ||
| Selling, General and Administrative Expense | 2.36M | ||
| Operating Income | -4.87M | ||
| Interest Expense | 10.70K | ||
| Net Income | -5.84M | ||
| Net Income Common Stock | -6.27M | ||
| Net Income Common Stock (USD) | -6.27M | ||
| Consolidated Income | -5.84M | ||
| Net Income from Discontinued Operations | 996.33K | ||
| Earnings per Basic Share | -1.43 | ||
| Earnings per Basic Share (USD) | -1.43 | ||
| Earnings per Diluted Share | -1.43 | ||
| Earning Before Interest & Taxes (EBIT) | -5.83M | ||
| Earning Before Interest & Taxes (USD) | -5.83M | ||
| Preferred Dividends Income Statement Impact | 431.66K | ||
| Weighted Average Shares | 4.70M | ||
| Weighted Average Shares Diluted | 4.70M | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.19M | ||
| Cash and Equivalents (USD) | 2.19M | ||
| Investments | 39.67K | ||
| Investments Current | 39.67K | ||
| Current Assets | 2.68M | ||
| Property, Plant & Equipment Net | 221.04K | ||
| Total Assets | 3.03M | ||
| Current Liabilities | 1.96M | ||
| Total Liabilities | 1.96M | ||
| Accumulated Retained Earnings (Deficit) | -130.23M | ||
| Accumulated Other Comprehensive Income | 128.57K | ||
| Shareholders Equity | 1.08M | ||
| Shareholders Equity (USD) | 1.08M | ||
| Assets Non-Current | 353.36K | ||
| Trade and Non-Trade Payables | 1.84M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 260.20K | ||
| Net Cash Flow from Financing | -1.00 | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.96M | ||
| Net Cash Flow from Operations | -2.96M | ||
| Share Based Compensation | 22.63K | ||